In this conversation with David Cassak, co-editor-in-chief of MedTech Strategist, Dr. Gottlieb will share his perspective on the challenges of regulating technologies and medicines during COVID-19 and discuss implications for the development and assessment of health technologies going forward.

Special thank you to our sponsors:

Wilson Sonsini Goodrich & Rosati
Fogarty Innovation